Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin
- 20 April 2005
- journal article
- hematologic malignancies
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (12), 2797-2804
- https://doi.org/10.1200/jco.2005.07.155
Abstract
Purpose: To study the main clinicobiologic features, response, and outcome of patients with diffuse large B-cell lymphoma (DLBCL) according to the primary site, lymph node, or different extranodal organs of the disease. Patients and Methods: We included 382 patients consecutively diagnosed with DLBCL in a single institution during a 13-year period. Morphology, immunophenotyping, proliferation index, differentiation profile, bcl-2/JH rearrangement, and clinical characteristics were analyzed according to the primary site of the lymphoma. Results: Sites of the disease were: lymph node, 222 cases (58%); Waldeyer's ring (WR), 42 (11%); and extranodal sites, 118 (31%), including GI tract in 45 cases. Primary extranodal cases, particularly GI, showed a bcl-6 expression more frequently than nodal cases. Patients with primary WR or GI lymphomas presented with early-stage disease, no marrow infiltration, normal serum lactate dehydrogenase, and low- to low/intermediate-risk international prognostic index (IPI) more frequently than the remainder. Complete response (CR) rate was 63%, with WR and GI lymphomas having a higher CR rate (85% and 80%, respectively) than the other groups. In the whole series, 5-year overall survival (OS) was 52%. Patients with WR or GI lymphomas showed better OS (5-year OS: 77% and 68%, respectively) than patients with nodal or other extranodal sites. In the multivariate analysis, IPI, bulky disease, and β2-microglobulin were the main variables to predict OS; no nodal or extranodal site maintained their prognostic value. Conclusion: In the present series, the primary site of disease was associated with particular clinicopathologic features and outcome, though the latter largely depended on other factors.This publication has 35 references indexed in Scilit:
- Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registryAnnals of Oncology, 2003
- Extranodal lymphomasAnnals of Oncology, 2000
- Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995JNCI Journal of the National Cancer Institute, 2000
- Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sitesAnnals of Oncology, 1999
- The epidemiology of non-Hodgkin's lymphoma: Comparison of nodal and extra-nodal sitesInternational Journal of Cancer, 1997
- Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomasAnnals of Oncology, 1997
- Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomasEuropean Journal of Cancer and Clinical Oncology, 1991
- Primary extranodal and nodal non-Hodgkin's lymphoma: A survey of a population-based registryEuropean Journal of Cancer and Clinical Oncology, 1989
- Primary extranodal lymphoma.Response to treatment and factors influencing prognosisCancer, 1978
- Occurrence and prognosis of extranodal lymphomasCancer, 1972